Global Innovation Fund invests $500,000 in Reme-D
Equity backing supports locally manufactured diagnostics for underserved healthcare settings.
Global Innovation Fund announced a $500,000 equity investment in Reme-D on 2 April 2026.
The investment supports a new manufacturing facility and expansion across Africa and the Middle East. Reme-D develops locally produced molecular tests designed to remain usable without continuous refrigeration.
Use of funds
Manufacturing facility expansion
African and Middle Eastern market access